- Home
- ROIV vs WPP Comparison
ROIV vs WPP Comparison
Compare ROIV & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- WPP
- Stock Information
- Founded
- ROIV 2014
- WPP 1985
- Country
- ROIV United Kingdom
- WPP United Kingdom
- Employees
- ROIV N/A
- WPP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- WPP Advertising
- Sector
- ROIV Health Care
- WPP Consumer Discretionary
- Exchange
- ROIV Nasdaq
- WPP Nasdaq
- Market Cap
- ROIV 7.8B
- WPP 7.7B
- IPO Year
- ROIV N/A
- WPP N/A
- Fundamental
- Price
- ROIV $10.99
- WPP $36.37
- Analyst Decision
- ROIV Buy
- WPP Sell
- Analyst Count
- ROIV 4
- WPP 1
- Target Price
- ROIV $17.50
- WPP N/A
- AVG Volume (30 Days)
- ROIV 7.3M
- WPP 361.7K
- Earning Date
- ROIV 08-07-2025
- WPP 08-06-2025
- Dividend Yield
- ROIV N/A
- WPP 7.18%
- EPS Growth
- ROIV N/A
- WPP 389.11
- EPS
- ROIV N/A
- WPP 0.62
- Revenue
- ROIV $29,053,000.00
- WPP $18,454,623,978.00
- Revenue This Year
- ROIV $2.64
- WPP N/A
- Revenue Next Year
- ROIV $378.09
- WPP $1.46
- P/E Ratio
- ROIV N/A
- WPP $11.31
- Revenue Growth
- ROIV N/A
- WPP N/A
- 52 Week Low
- ROIV $8.73
- WPP $31.52
- 52 Week High
- ROIV $13.06
- WPP $57.37
- Technical
- Relative Strength Index (RSI)
- ROIV 44.75
- WPP 47.48
- Support Level
- ROIV $10.83
- WPP $34.90
- Resistance Level
- ROIV $11.82
- WPP $35.42
- Average True Range (ATR)
- ROIV 0.32
- WPP 0.59
- MACD
- ROIV -0.07
- WPP 0.13
- Stochastic Oscillator
- ROIV 16.24
- WPP 64.35
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.